Showing results out of
Nicolas Foos, a postdoctoral fellow at EMBL Grenoble, talks about the implementation of a new method for in situ serial crystallography developed during his ARISE fellowship.
SCIENCE & TECHNOLOGY2024
science-technology
EMBL Grenoble and University of Geneva researchers shed light on the molecular activation of the MAP kinase p38α, the final ‘switch’ triggering the inflammatory response.
SCIENCE & TECHNOLOGY2023
sciencescience-technology
EMBL Grenoble technology teams provide a sneak peek into their latest collaborative project in structural biology services: the complete automation of an integral step in X-ray crystallography.
EMBLetc2023
EMBL Grenoble researchers have investigated the interaction between THC and some proteins it might bind to. In a recent study, they showed in vitro that THC inhibits an important human enzyme called autotaxin.
SCIENCE & TECHNOLOGY2023
sciencescience-technology
Researchers and engineers have integrated a CrystalDirect harvester into the fully automated beamline MASSIF-1, a unique combination of structural biology technologies that is now open to external academic users.
LAB MATTERSSCIENCE & TECHNOLOGY2022
lab-mattersscience-technology
The recent construction of the new ID29 beamline in Grenoble is pioneering a new way of doing experiments in time-resolved crystallography and opening up technology transfer possibilities
LAB MATTERSSCIENCE & TECHNOLOGY2022
lab-mattersscience-technology
The beamlines run jointly by EMBL Grenoble and the ESRF reopen today, unveiling significant upgrades that exploit the brand new fourth generation ESRF synchrotron source.
EMBL ANNOUNCEMENTS2020
embl-announcementsscience
No results found